AstraZeneca Proposes USD 1.5 Billion Manufacturing Facility

AstraZeneca, a pharmaceutical firm, expects to construct a $1.5 billion manufacturing facility in Singapore for antibody-drug conjugates (ADCs), upgrading the worldwide stockpile of its ADC portfolio. ADCs are cutting-edge therapies that potent...

Implicity Bags US FDA Nod For New heart failure Prediction Algorithm

Implicity announced that company has received 510(k) clearance from the US Food and Drug Administration (FDA) for SignalHF, a new groundbreaking algorithm used in its remote monitoring solution. Implicity was the first...

Glenmark Pharma Bags US FDA Nod For Ophthalmic Solution

Glenmark Pharmaceuticals Ltd. (Glenmark) has acquired final approval from the US Food and Drug Administration (FDA) for brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5%. The FDA has decided that Glenmark's brimonidine...

Roche Bags US FDA Nod for its human papillomavirus self-collection solutions

Roche reported that its human papillomavirus (HPV) self-collection solution, which was among the first available in the United States, has been approved by the US FDA. Screening for HPV can assist identify women who are at risk of getting...

Glenmark amplifies Nationwide Heart Health Initiative with the Next Phase of India First Heart First Campaign

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceuticals company, proudly announced the launch of the next phase of ‘India First Heart First’ campaign.

Atraverse Medical Secures US FDA Approval For HOTWIRE System

Atraverse Medical, a medical device company spearheading cutting edge left-heart access innovation, has reported the US FDA approval of its HOTWIRE radiofrequency (RF) guidewire, a novel device that empowers zero trade left-heart access while...

Centogene and Evotec Discover New molecule To Treat Gaucher Ailment

Centogene NV, the crucial life science partner for data-driven answers in rare and neurological illnesses, has announced the discovery of a new small molecule alongside Evotec SE. The novel chemical has the potential to help individuals with type...

Chiesi Group and Karolinska Institutet Ink MoU To Tackle Health Challenges

Chiesi Group, a pharmaceutical firm, declared the marking of a memorandum of understanding with Karolinska Institutet, a medical university. The understanding cements a responsibility between the two associations to team up on joint endeavors...

Mankind Pharma's Q4 Profit Rises on Strength in Chronic Drugs Segment

Mankind Pharma, a pharmaceutical firm, posted more than 65% in its final quarter profit, assisting areas of strength by request in its chronic drugs segment. The organization has also sanctioned a fundraising of up to 75 billion rupees or an...

Boehringer Ingelheim Secures CDSCO Approval For Drug To treat GPP

Boehringer Ingelheim, a pharmaceutical firm, added that the domestic medication controller has endorsed a medication for Generalised Pustular Psoriasis (GPP) flares in grown-ups. The organization has secured an endorsement from the Central Drugs...

© 2024 India Pharma Outlook. All Rights Reserved.